Efficacy and tolerability of mirabegron, a β3-adrenoceptor agonist, in patients with overactive bladder: Results from a randomised European-Australian phase 3 trial
- Khullar, V.
- Amarenco, G.
- Angulo, J.C.
- Cambronero, J.
- Høye, K.
- Milsom, I.
- Radziszewski, P.
- Rechberger, T.
- Boerrigter, P.
- Drogendijk, T.
- Wooning, M.
- Chapple, C.
ISSN: 0302-2838, 1873-7560
Any de publicació: 2013
Volum: 63
Número: 2
Pàgines: 283-295
Tipus: Article